About Angelini Ventures
Angelini Ventures provides ideas and solutions in biotechnology, digital health, and life sciences. The company offers services such as digital health solutions, tech-enabled care delivery, treatments for the central nervous system (CNS), and more. It was founded in 2021 and is based in Rome, Italy.
Latest Angelini Ventures News
Jun 30, 2023
Dowe moves to Angelini Ventures Jun 30, 2023 • Kim Moore Tanja Dowe has a more than 20-year career in the life sciences and biotechnology sectors. Tanja Dowe Tanja Dowe has joined Angelini Ventures, the corporate venture arm of Italian industrial company Angelini Industries, as managing director. Dowe was previously CEO of Debiopharm Innovation Fund, the strategic investment arm of Debiopharm Group, a Swiss biopharmaceutical company. Angelini Ventures was set up last year as a €300m global venture capital fund focussed on biotechnology, digital health and life sciences. LEADERSHIP SOCIETY Informing, connecting, and transforming the global corporate venture capital ecosystem. The Global Corporate Venturing (GCV) Leadership Society’s mission is to help bridge the different strengths and ambitions of investors across industry sectors, geography, structure, and their returns.
Angelini Ventures Frequently Asked Questions (FAQ)
When was Angelini Ventures founded?
Angelini Ventures was founded in 2021.
Where is Angelini Ventures's headquarters?
Angelini Ventures's headquarters is located at Viale Amelia 70, Rome.